title: Intracranial hemangiopericytoma: study of 12 cases.
abstract: Most hemangiopericytomas (HPCs) are located in the musculoskeletal system and the skin, while the intracranial location is rare. They represent 2 to 4% in large series of meningeal tumours, thus accounting for less than 1% of all intracranial tumours. Many authors have argued about the true origin of this tumour. The current World Health Organization classification of Central Nervous System tumours distinguishes HPC as an entity of its own, and classified it into the group of "mesenchymal, non-meningothelial tumours". Radical surgery is the treatment of choice, but must be completed with postoperative radiotherapy, which has proved to be the therapy most strongly related to the final prognosis. HPCs have a relentless tendency for local recurrence and metastases outside the central nervous system which can appear even many years after diagnosis and adequate treatment of the primary tumour. Twelve patients with intracranial HPC were treated at our Unit between 1978 and 1999. There were 10 women and 2 men. Ten tumours were supratentorial and most located at frontoparietal parasagittal level. The most common manner of presentation was a focal motor deficit. All tumours were hyperdense in the basal Computed Tomography scans and most enhanced homogeneously following intravenous contrast injection. In 50% of cases, tumour margins were irregular or lobulated. Seven tumours were studied with Magnetic Resonance Imaging, being six of them iso-intense with the cortical gray matter on T1-weighted and T2-weighted images. Twenty operations were performed in the 12 patients. In 10 cases radical excision could be achieved with no operative mortality. Total recurrence rate was 33.3%. Eight patients were treated with external radiotherapy at some time through the course of their disease. Eight out of the 12 patients in this series are disease-free (Glasgow Outcome Scale categories 1 and 2) after a mean follow up of 52 months.
authors.affiliation: Neurosurgical Service, Neuroradiology, Hospital Doce de Octubre, Madrid, Spain.
authors.forename: J F
authors.initials: JF
authors.lastname: Alén
authors.forename: R D
authors.initials: RD
authors.lastname: Lobato
authors.forename: P A
authors.initials: PA
authors.lastname: Gómez
authors.forename: G R
authors.initials: GR
authors.lastname: Boto
authors.forename: A
authors.initials: A
authors.lastname: Lagares
authors.forename: A
authors.initials: A
authors.lastname: Ramos
authors.forename: J R
authors.initials: JR
authors.lastname: Ricoy
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001921:Brain / Q000000981:diagnostic imaging / Q000473:pathology*; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000532:radiotherapy / Q000601:surgery; D003399:Craniotomy; D003937:Diagnosis, Differential; D005260:Female; D006393:Hemangiopericytoma / Q000175:diagnosis* / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D008297:Male; D008577:Meningeal Neoplasms / Q000175:diagnosis* / Q000532:radiotherapy / Q000601:surgery; D008579:Meningioma / Q000175:diagnosis; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D011859:Radiography; D012086:Reoperation; D016019:Survival Analysis; D016896:Treatment Outcome